| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44e0905262f429c7590b40df8448c0c5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06 |
| filingDate |
2017-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e9446a20ddd779eb42f1b247abab660
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c09ac854891929ef53cc387fbc9e0065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ba61ea1e9feeac1529340519c70c4b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2454674f9eea98fdd196d2084056c2f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04bab4b37a8f14894751cf62e95c371a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9e7a499feacf6b7f1e2c4d4ef936d7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fdaeadf0d1d2eb3a274d362a1d46c1c |
| publicationDate |
2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2018048122-A |
| titleOfInvention |
Tapentadol for preventing chronic pain |
| abstract |
[PROBLEMS] To provide a medicine and a dosage method having advantages compared to the prior art for preventing chronic pain. A pharmaceutical composition comprising tapentadol for use in the treatment of pain in a subject suffering from chronicity of pain and / or for use in the treatment or prevention of chronicity of pain. Tapentadol during the phase O 1 consecutive M 1 day, is administered in combination with other analgesics, during the successive M 2 days phase O 2 immediately after the phase O 1 is not administered (M 1 And M 2 is independently an integer from 1 to 100). [Selection figure] None |
| priorityDate |
2011-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |